Orgovyx 120 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FXHKC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,386
Award facts
- Contract value 100% obligated
- $1,385.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets (30-count units). This firm fixed-price, non-set-aside delivery order was awarded on November 4, 2025, with an ultimate completion date of November 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply pharmaceuticals and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains a comprehensive portfolio of federal contract awards with the DLA for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. ORGOVYX is a prescription medication used in the treatment of prostate cancer, reflecting the breadth of therapeutic domains supported through AmerisourceBergen's federal contracts. All reviewed contract awards with this vendor have been competitively awarded without set-asides, demonstrating the company's capability to meet federal procurement requirements in open competition.
Quick answers
Who was awarded contract SPE2DB26FXHKC?
SPE2DB26FXHKC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FXHKC worth?
The government has obligated $1,386 on SPE2DB26FXHKC.
Is contract SPE2DB26FXHKC an order under another contract?
Yes. SPE2DB26FXHKC is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB26FXHKC competed?
The extent of competition for SPE2DB26FXHKC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award